20.80
+0.90
+(4.52%)
At close: January 31 at 8:06:35 AM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
419,416,000.00
409,925,000.00
243,582,000.00
279,626,000.00
205,035,000.00
Investing Cash Flow
-204,818,000.00
-37,290,000.00
-145,465,000.00
-118,927,000.00
-98,312,000.00
Financing Cash Flow
-141,275,000.00
-139,331,000.00
-145,641,000.00
-107,408,000.00
-99,497,000.00
End Cash Position
404,664,000.00
458,674,000.00
222,169,000.00
267,753,000.00
212,333,000.00
Capital Expenditure
-71,689,000.00
-74,258,000.00
-71,239,000.00
-72,866,000.00
-61,411,000.00
Issuance of Capital Stock
202,000.00
217,000.00
241,000.00
322,000.00
440,000.00
Repurchase of Capital Stock
-6,000.00
--
-5,000.00
-8,000.00
-30,000.00
Free Cash Flow
347,727,000.00
335,667,000.00
172,343,000.00
206,760,000.00
143,624,000.00
12/31/2020 - 4/29/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GRF.VI Grifols, S.A.
8.43
-0.26%
0RDV.IL Grifols, S.A.
6.67
-0.37%
AZN.ST AstraZeneca PLC
1,566.00
+0.64%
AZN.L AstraZeneca PLC
11,344.00
+0.27%
AZN AstraZeneca PLC
70.76
-0.67%
AMGN Amgen Inc.
285.42
+0.49%
NOVO-B.CO Novo Nordisk A/S
607.30
+0.60%
MRK Merck & Co., Inc.
98.82
-0.13%
NVO Novo Nordisk A/S
84.45
-1.04%
LLY Eli Lilly and Company
811.08
-1.48%